Cost of illness for neuromuscular diseases in the United States

Emerging drugs for Duchenne muscular dystrophy

(2012) Vinod Malik et al.   EXPERT OPINION ON EMERGING DRUGS

Therapeutics development in myotonic dystrophy type 1

(2011) Erin Pennock Foff et al.   MUSCLE & NERVE

Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy

(2009) Karsten Schepelmann et al.   JOURNAL OF NEUROLOGY

The costs of amyotrophic lateral sclerosis, according to type of care

(2008) Irene Van Der Steen et al.   Amyotrophic Lateral Sclerosis

Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain

(2008) Julio López-Bastida et al.   Amyotrophic Lateral Sclerosis

Health Care Utilization and Expenditures for Children and Young Adults With Muscular Dystrophy in a Privately Insured Population

(2008) Lijing Ouyang et al.   JOURNAL OF CHILD NEUROLOGY